Webログイン: JCOG Web System 個人アカウント: パスワード: 個人アカウント・パスワードを忘れた方はこちら Webrandomized phase III study comparing continuation and discontinuation of PD-1 pathway inhibitors for patients with advanced non-small-cell lung cancer (JCOG1701, SAVE study) Japanese Journal of Clinical Oncology
生物統計情報学講座 特任講師 野村 尚吾 東京大学大学院 医学系 …
Web19 mag 2024 · @article{Nomura2024ARP, title={A randomized phase III study comparing continuation and discontinuation of PD-1 pathway inhibitors for patients with advanced non-small-cell lung cancer (JCOG1701, SAVE study).}, author={Shogo Nomura and Yasushi Goto and Tomonori Mizutani and Tomoko Kataoka and Shoko Kawai and Yusuke … WebJCOG1701: 非小細胞肺癌に対するPD-1経路阻害薬の継続と休止に関するランダム化比較第III相試験 順天堂大学臨床研究情報検索システム. 最終更新日：2024年05月10日. 一般 … prubsn payment online
COI 開示 - JCOG
Web5 feb 2024 · Campi del modello F24. come compilare il campo. (1) codice tributo: indicare 1701. (2) rateazione/regione/prov/mese rif: 03. (3) anno di riferimento: Anno in cui è … WebTomonori Mizutani's 39 research works with 381 citations and 2,167 reads, including: Patient-reported outcome and quality of life research policy: Japan Clinical Oncology Group (JCOG) policy WebWe would like to thank Dr. Yuichiro Ohe, Dr. Yasushi Goto, and Dr. Hidehito Horinouchi at National Cancer Center Hospital, Japan for permission to use design details of the SAVE study (JCOG1701) as an application example. We also thank the Editor, the Associate Editor, and two anonymous referees for their helpful comments. prucal bonds